Finance Construction / Development Equipment Finance / Leasing Real Estate Finance Real Estate Corporate Real Estate Leasing Real Estate Acquisitions & Sales Real Estate Development Condominium & Planned Unit Development Marcellus Shale
ISLN:
906648580
Admitted:
1975
University:
University of Pittsburgh, B.A., 1972
Law School:
University of Pittsburgh School of Law, J.D., 1975
Ronald D. Hartman - Odessa FL, US Douglas A. Chamberlin - Trinity FL, US Kim R. Heinicka - Seminole FL, US John Koss - Fort Worth TX, US Bryan Williams - Novi MI, US Brandon Noska - Austin TX, US
Assignee:
Honeywell International Inc. - Morristown NJ
International Classification:
G01B 11/02
US Classification:
356510
Abstract:
A system to determine unwanted noise produced by simulation equipment. In one embodiment, an angular rotation noise measuring system comprises a stable body, a laser, at least one interferometer and at least one mirror. The laser is adapted to generate a primary laser beam and is mounted to the stable body. The at least one interferometer is adapted to split the primary laser beam into two or more out of phase secondary laser beams. Moreover, the interferometer is coupled to the stable body. The at least one mirror is coupled to a fixture on a vibration generating device. The fixture is adapted to hold a device under test. Each mirror is adapted to reflect an associated secondary laser beam back to the interferometer such that an interference pattern is formed with the secondary laser beams. Changes to the interference pattern determine the angular rotation noise caused by the vibration generating device.
Ronald Blair Hartman - Leawood KS, US Renee Marie Hartman - Leawood KS, US
International Classification:
A61K 31/4985 A61K 45/06 A61K 31/09 A61K 31/353
Abstract:
A drug developed to treat dementia which has been abandoned by its manufacturer, Novartis, is repurposed to enhance the treatment of cancer. The drug, Ergoloid, contains four gamma secretase inhibitors that produce the same benefit as single gamma secretase inhibitors that are in clinical trials to enhance the treatment of cancer. The method of this invention is to administer Ergoluid mg three times a day by mouth.This enhancement results in better outcomes with lower cost and better quality of life.
Dr. Hartman graduated from the New York Medical College in 1960. He works in Los Alamitos, CA and 1 other location and specializes in Ophthalmology. Dr. Hartman is affiliated with Lakewood Regional Medical Center and Los Alamitos Medical Center.
Dr. Hartman graduated from the Johns Hopkins University School of Medicine in 1976. He works in Leawood, KS and specializes in Internal Medicine. Dr. Hartman is affiliated with Shawnee Mission Medical Center Inc.